Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

1606 (CBDW) EBIT (2021 - 2025)

1606 has reported EBIT over the past 5 years, most recently at -$82976.0 for Q4 2025.

  • Quarterly EBIT rose 59.59% to -$82976.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$485738.0 through Dec 2025, up 88.26% year-over-year, with the annual reading at -$485738.0 for FY2025, 88.26% up from the prior year.
  • EBIT was -$82976.0 for Q4 2025 at 1606, up from -$111446.0 in the prior quarter.
  • Over five years, EBIT peaked at -$14701.0 in Q1 2021 and troughed at -$3.2 million in Q3 2024.
  • The 5-year median for EBIT is -$149731.5 (2022), against an average of -$354390.2.
  • Year-over-year, EBIT plummeted 891.54% in 2022 and then surged 96.57% in 2025.
  • A 5-year view of EBIT shows it stood at -$97205.0 in 2021, then plummeted by 58.12% to -$153697.0 in 2022, then crashed by 99.24% to -$306230.0 in 2023, then soared by 32.95% to -$205318.0 in 2024, then surged by 59.59% to -$82976.0 in 2025.
  • Per Business Quant, the three most recent readings for CBDW's EBIT are -$82976.0 (Q4 2025), -$111446.0 (Q3 2025), and -$117084.0 (Q2 2025).